Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | F10 | P00742 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.41 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 3/20 | 0.41 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | F7 | P08709 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | F3 | P13726 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24363870 | 0.77 | SLC6A2 (0.40) | CHRNB2CHRNA7CHRNA4IMPDH2IMPDH1 | |
| SCHEMBL8995188 | 0.76 | AHR (0.46) | IMPDH2IMPDH1AHRNR4A2CYP2A6 | |
| SCHEMBL18000304 | 0.75 | AHR (0.48) | IMPDH2IMPDH1AHRNR4A2CYP2A6 | |
| SCHEMBL17529943 | 0.75 | CHRNB2 (0.46) | L3MBTL1CHRNB2CHRNA7CHRNA4CYP2A6 | |
| SCHEMBL19580684 | 0.75 | L3MBTL1 (0.55) | L3MBTL1CHRNB2CHRNA7CHRNA4CYP2A6 | |
| SCHEMBL31481180 | 0.75 | L3MBTL1 (0.55) | L3MBTL1CHRNB2CHRNA7CHRNA4CYP2A6 | |
| SCHEMBL3307955 | 0.75 | NPC1 (0.47) | IMPDH2IMPDH1AHRNR4A2CYP2A6 | |
| SCHEMBL22342845 | 0.75 | L3MBTL1 (0.55) | L3MBTL1CHRNB2CHRNA7CHRNA4CYP2A6 | |
| SCHEMBL30241239 | 0.75 | L3MBTL1 (0.51) | L3MBTL1CHRNB2CHRNA7CHRNA4CYP2A6 | |
| SCHEMBL25973030 | 0.75 | L3MBTL1 (0.55) | L3MBTL1CHRNB2CHRNA7CHRNA4CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230121302-A1 | METHODS OF IRON CATALYZED C-H BOND AMINATION | VERSITECH LIMITED (CN) | 2023-04-20 | — | — | US | disclosed |
| WO-2019183472-A1 | MELANOCORTIN RECEPTOR-SPECIFIC PEPTIDE FORMULATIONS AND METHODS FOR GASTROINTESTINAL TRACT-SPECIFIC DELIVERY | PALATIN TECHNOLOGIES, INC. (US) | 2019-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230121302-A1 | METHODS OF IRON CATALYZED C-H BOND AMINATION | FTH1, FECH, HCCS | L3MBTL1 4295/4885F10 716/4885CHRNB2 4674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.